Tags

Type your tag names separated by a space and hit enter

The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Menopause 2010; 17(4):727-33M

Abstract

OBJECTIVE

The aim of this study was to describe a unique model of multidisciplinary care for women with menopausal symptoms after breast cancer and present preliminary data for 653 women.

METHODS

The nature and severity of menopausal symptoms in women with breast cancer were measured using a standardized scale.

RESULTS

A total of 578 women with breast cancer were managed at the Menopausal Symptoms After Cancer Clinic between January 2003 and December 2008. The most common reasons for these women to seek treatment were hot flushes (41%), night sweats (36%), loss of interest in sex (30%), difficulty sleeping (25%), and fatigue (22%). Extreme vaginal dryness was also reported in 19% of these women. Chemotherapy-induced ovarian failure was reported by 29% of the breast cancer patients seen. A range of management approaches were offered, with 55% of the women prescribed nonhormonal pharmacological therapies for vasomotor symptoms, including vitamin E 400 IU twice daily (21%), venlafaxine 75 mg CR once daily (13%), clonidine 50 microg twice daily (11%), or gabapentin 300 mg three times daily (4%).

CONCLUSIONS

Vasomotor symptoms, sexual dysfunction, and sleep disturbance are the most distressing menopausal symptoms requiring management after breast cancer. Menopausal symptom management after breast cancer may be complex, and we present a novel model of care using a multidisciplinary approach. Additional benefits of this multidisciplinary approach include education opportunities, improved communication and networking opportunities, and decision making in line with evidence-based guidelines.

Authors+Show Affiliations

School of Women's and Infants' Health, King Edward Memorial Hospital, The University of Western Australia, Crawley, WA, Australia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20512079

Citation

Hickey, Martha, et al. "The Multidisciplinary Management of Menopausal Symptoms After Breast Cancer: a Unique Model of Care." Menopause (New York, N.Y.), vol. 17, no. 4, 2010, pp. 727-33.
Hickey M, Emery LI, Gregson J, et al. The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause. 2010;17(4):727-33.
Hickey, M., Emery, L. I., Gregson, J., Doherty, D. A., & Saunders, C. M. (2010). The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause (New York, N.Y.), 17(4), pp. 727-33. doi:10.1097/gme.0b013e3181d672f6.
Hickey M, et al. The Multidisciplinary Management of Menopausal Symptoms After Breast Cancer: a Unique Model of Care. Menopause. 2010;17(4):727-33. PubMed PMID: 20512079.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. AU - Hickey,Martha, AU - Emery,Laura I, AU - Gregson,Jane, AU - Doherty,Dorota A, AU - Saunders,Christobel M, PY - 2010/6/1/entrez PY - 2010/6/1/pubmed PY - 2010/11/3/medline SP - 727 EP - 33 JF - Menopause (New York, N.Y.) JO - Menopause VL - 17 IS - 4 N2 - OBJECTIVE: The aim of this study was to describe a unique model of multidisciplinary care for women with menopausal symptoms after breast cancer and present preliminary data for 653 women. METHODS: The nature and severity of menopausal symptoms in women with breast cancer were measured using a standardized scale. RESULTS: A total of 578 women with breast cancer were managed at the Menopausal Symptoms After Cancer Clinic between January 2003 and December 2008. The most common reasons for these women to seek treatment were hot flushes (41%), night sweats (36%), loss of interest in sex (30%), difficulty sleeping (25%), and fatigue (22%). Extreme vaginal dryness was also reported in 19% of these women. Chemotherapy-induced ovarian failure was reported by 29% of the breast cancer patients seen. A range of management approaches were offered, with 55% of the women prescribed nonhormonal pharmacological therapies for vasomotor symptoms, including vitamin E 400 IU twice daily (21%), venlafaxine 75 mg CR once daily (13%), clonidine 50 microg twice daily (11%), or gabapentin 300 mg three times daily (4%). CONCLUSIONS: Vasomotor symptoms, sexual dysfunction, and sleep disturbance are the most distressing menopausal symptoms requiring management after breast cancer. Menopausal symptom management after breast cancer may be complex, and we present a novel model of care using a multidisciplinary approach. Additional benefits of this multidisciplinary approach include education opportunities, improved communication and networking opportunities, and decision making in line with evidence-based guidelines. SN - 1530-0374 UR - https://www.unboundmedicine.com/medline/citation/20512079/The_multidisciplinary_management_of_menopausal_symptoms_after_breast_cancer:_a_unique_model_of_care_ L2 - http://Insights.ovid.com/pubmed?pmid=20512079 DB - PRIME DP - Unbound Medicine ER -